Publikation
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
Wissenschaftlicher Artikel/Review - 28.04.2011
von Moos R, Dummer R, Schönewolf N, Mamot C, Mjhic-Probst D, Schraml P H, Moch H, Schläppi M, Cathomas R, Michielin O, Ochsenbein A, Gillessen S, Goldinger S M, Simcock M, Seifert B, on behaalf of the Swiss Group for Clinical Cancer Research (SAKK)
von Moos, R
25
0
Seifert, B
4
0
Simcock, M
3
0
Goldinger, S M
3
0
Gillessen, S
7
0
Ochsenbein, A
4
0
Michielin, O
1
0
Cathomas, R
20
0
Schläppi, M
1
0
Moch, H
7
0
Schraml, P H
1
0
Mjhic-Probst, D
1
0
Mamot, C
2
0
Schönewolf, N
1
0
Dummer, R
17
0
on behaalf of the Swiss Group for Clinical Cancer Research (SAKK),
1
0